Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNP vs NTG During Angioplasty
NCT00262574Phase 4Unknown
- Sponsor
- Tzafon Medical Center
- Start
- Jul 2005
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of nesiritide in coronary artery disease (CAD) (2 arms), sponsored by Tzafon Medical Center. Primary endpoint: Flow-mediated Brachial Artery Dilation at 3 years. Status: unknown.
02
Drugs
nesiritide
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00262574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262574.